StockData
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. (XENE) stock

XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$37.75−1.03 (-2.66%)

Close on Nov 18, 2026Market cap $3.66BP/E –Yield –

Xenon Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Xenon Pharmaceuticals's market cap was $4.07B on Nov 11, 2026, against $3.45B a year earlier. Over the last 5 years it ranged from $1.12B to $6.06B, with a median of $2.92B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.07B+17.8%
2025Dec 31, 2025$3.46B+16.3%
2024Dec 31, 2024$2.97B-0.8%
2023Dec 29, 2023$2.99B+21.4%
2022Dec 30, 2022$2.47B+90.6%
2021Dec 31, 2021$1.29B+140.4%
2020Dec 31, 2020$538.22M+58.7%
2019Dec 31, 2019$339.14M+113.4%
2018Dec 31, 2018$158.93M+212.6%
2017Dec 29, 2017$50.85M-63.1%
2016Dec 30, 2016$137.78M+19.5%
2015Dec 31, 2015$115.33M+332.7%
2014Dec 31, 2014$26.65M–

More Xenon Pharmaceuticals figures

See a number that looks wrong?